Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child
暂无分享,去创建一个
L. Kalish | L. Mofenson | M. Fowler | D. Burns | C. Zorrilla | H. Minkoff | H. Minkoff | S. Landesman | H. Fox | R. Tuomala | C. Zorilla | P. Garcia | David Burns
[1] L. Mofenson,et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission , 1996, AIDS.
[2] M. Sim,et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. , 1996, JAMA.
[3] D. Thea,et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. , 1995, Pediatrics.
[4] J. Goedert,et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus , 1995 .
[5] G. Pardi,et al. The incidence of complications after caesarean section in 156 HIV‐positive women , 1995, AIDS.
[6] J. Goedert,et al. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. , 1995, The Journal of pediatrics.
[7] L. Mofenson,et al. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus , 1995, The Pediatric infectious disease journal.
[8] C. Rouzioux,et al. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[9] R. Gelber,et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.
[10] L. Mofenson,et al. The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus infection. , 1994, American journal of obstetrics and gynecology.
[11] J. Goedert,et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies. , 1994, Journal of acquired immune deficiency syndromes.
[12] D. Brambilla,et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group. , 1994, The Journal of infectious diseases.
[13] N. Shaffer,et al. A prospective population-based study of HIV perinatal transmission , 1994, AIDS.
[14] J. Goedert,et al. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. , 1994, Journal of acquired immune deficiency syndromes.
[15] W. Tsai,et al. Maternal-infant HIV transmission and circumstances of delivery. , 1994, American journal of public health.
[16] Y. Bryson,et al. Factors predictive of maternal-fetal transmission of HIV-1-preliminary analysis of zidovudine given during pregnancy and/or delivery , 1994 .
[17] G. Pardi,et al. Caesarean section and risk of vertical transmission of HIV-1 infection , 1994, The Lancet.
[18] M. Essex,et al. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women , 1994, The Lancet.
[19] G. Pardi,et al. Perinatal findings in children born to HIV‐infected mothers , 1994, British journal of obstetrics and gynaecology.
[20] O. Bagasra,et al. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. , 1993, The Journal of infectious diseases.
[21] T. Chalmers,et al. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. , 1993, The Online journal of current clinical trials.
[22] A. Landay,et al. Prediction of CD4 count from CD4 percentage: experience from three laboratories. , 1993, AIDS.
[23] T. Quinn,et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. , 1993, JAMA.
[24] K. Holmes,et al. Detection of HIV DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya , 1993, JAMA.
[25] E. Karita,et al. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. , 1993, American journal of epidemiology.
[26] S. Seiden,et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. , 1993, Journal of acquired immune deficiency syndromes.
[27] L. Montagnier,et al. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. , 1993, Journal of acquired immune deficiency syndromes.
[28] C. Giaquinto,et al. Risk factors for mother‐to‐child transmission of HIV‐1 , 1992 .
[29] C. Griscelli,et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates , 1992, The New England journal of medicine.
[30] C. Giaquinto,et al. Mother-to-child transmission of human immunodeficiency virus type 1: risk of infection and correlates of transmission. , 1992, Pediatrics.
[31] F. Dabis,et al. Characteristics of newborns and HIV-1 infection in Rwanda. , 1992, AIDS.
[32] J. Bremer,et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories , 1992, Journal of clinical microbiology.
[33] J. Goedert,et al. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. , 1992, The Journal of clinical investigation.
[34] R. Henrion,et al. HIV replication during the first weeks of life , 1992, The Lancet.
[35] B. Wahrén,et al. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. , 1992, Journal of acquired immune deficiency syndromes.
[36] J. Goedert,et al. High risk of HIV-1 infection for first-born twins , 1991, The Lancet.
[37] S. Lindgren,et al. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. , 1991, AIDS.
[38] A. Sönnerborg,et al. HIV in pregnant women and their offspring: evidence for late transmission , 1991, The Lancet.
[39] C. Ou,et al. Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. , 1991, The Pediatric infectious disease journal.
[40] H. Balfour,et al. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. , 1991, Journal of immunology.
[41] H. Balfour,et al. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. , 1990, AIDS.
[42] A. Rubinstein,et al. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Wahrén,et al. Mother-to-infant transmission of HIV , 1990, The Lancet.
[44] P. Selwyn,et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers , 1989, Disease markers.
[45] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[46] J. Goedert,et al. MOTHER-TO-INFANT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: ASSOCIATION WITH PREMATURITY OR LOW ANTI-gp120 , 1989, The Lancet.
[47] T. Quinn,et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. , 1989, The New England journal of medicine.
[48] J M Taylor,et al. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. , 1989, Journal of acquired immune deficiency syndromes.
[49] D. Corcoran,et al. Circulating lymphocyte subpopulations in pregnancy: a longitudinal study. , 1984, Journal of immunology.
[50] B. Sachs,et al. Cesarean section. Risk and benefits for mother and fetus. , 1983, JAMA.
[51] Nitin R. Patel,et al. A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .
[52] Arthur Schafer,et al. Ethics of the randomized clinical trial. , 1982, The New England journal of medicine.
[53] P. Greipp,et al. Decreased levels of helper T cells in pregnancy. , 1982, The New England journal of medicine.
[54] W. Cleveland. Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .